Global Inactivated Polio Virus Vaccine Market Growth (Status and Outlook) 2023-2029

January 2023 | 61 pages | ID: G8F1704F9265EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Inactivated Polio Virus Vaccine Industry Forecast” looks at past sales and reviews total world Inactivated Polio Virus Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Inactivated Polio Virus Vaccine sales for 2023 through 2029. With Inactivated Polio Virus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inactivated Polio Virus Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Inactivated Polio Virus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inactivated Polio Virus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inactivated Polio Virus Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inactivated Polio Virus Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inactivated Polio Virus Vaccine.

The global Inactivated Polio Virus Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Inactivated Polio Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Inactivated Polio Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Inactivated Polio Virus Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Inactivated Polio Virus Vaccine players cover Sanofi, GSK, Serum Institute (Bilthoven Biologicals) and IMBCA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Inactivated Polio Virus Vaccine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Type I
• Type II
• Type III

Segmentation by application

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sanofi
• GSK
• Serum Institute (Bilthoven Biologicals)
• IMBCA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inactivated Polio Virus Vaccine Market Size 2018-2029
  2.1.2 Inactivated Polio Virus Vaccine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Inactivated Polio Virus Vaccine Segment by Type
  2.2.1 Type I
  2.2.2 Type II
  2.2.3 Type III
2.3 Inactivated Polio Virus Vaccine Market Size by Type
  2.3.1 Inactivated Polio Virus Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
2.4 Inactivated Polio Virus Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Inactivated Polio Virus Vaccine Market Size by Application
  2.5.1 Inactivated Polio Virus Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)

3 INACTIVATED POLIO VIRUS VACCINE MARKET SIZE BY PLAYER

3.1 Inactivated Polio Virus Vaccine Market Size Market Share by Players
  3.1.1 Global Inactivated Polio Virus Vaccine Revenue by Players (2018-2023)
  3.1.2 Global Inactivated Polio Virus Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Inactivated Polio Virus Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INACTIVATED POLIO VIRUS VACCINE BY REGIONS

4.1 Inactivated Polio Virus Vaccine Market Size by Regions (2018-2023)
4.2 Americas Inactivated Polio Virus Vaccine Market Size Growth (2018-2023)
4.3 APAC Inactivated Polio Virus Vaccine Market Size Growth (2018-2023)
4.4 Europe Inactivated Polio Virus Vaccine Market Size Growth (2018-2023)
4.5 Middle East & Africa Inactivated Polio Virus Vaccine Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Inactivated Polio Virus Vaccine Market Size by Country (2018-2023)
5.2 Americas Inactivated Polio Virus Vaccine Market Size by Type (2018-2023)
5.3 Americas Inactivated Polio Virus Vaccine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Inactivated Polio Virus Vaccine Market Size by Region (2018-2023)
6.2 APAC Inactivated Polio Virus Vaccine Market Size by Type (2018-2023)
6.3 APAC Inactivated Polio Virus Vaccine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Inactivated Polio Virus Vaccine by Country (2018-2023)
7.2 Europe Inactivated Polio Virus Vaccine Market Size by Type (2018-2023)
7.3 Europe Inactivated Polio Virus Vaccine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inactivated Polio Virus Vaccine by Region (2018-2023)
8.2 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Type (2018-2023)
8.3 Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INACTIVATED POLIO VIRUS VACCINE MARKET FORECAST

10.1 Global Inactivated Polio Virus Vaccine Forecast by Regions (2024-2029)
  10.1.1 Global Inactivated Polio Virus Vaccine Forecast by Regions (2024-2029)
  10.1.2 Americas Inactivated Polio Virus Vaccine Forecast
  10.1.3 APAC Inactivated Polio Virus Vaccine Forecast
  10.1.4 Europe Inactivated Polio Virus Vaccine Forecast
  10.1.5 Middle East & Africa Inactivated Polio Virus Vaccine Forecast
10.2 Americas Inactivated Polio Virus Vaccine Forecast by Country (2024-2029)
  10.2.1 United States Inactivated Polio Virus Vaccine Market Forecast
  10.2.2 Canada Inactivated Polio Virus Vaccine Market Forecast
  10.2.3 Mexico Inactivated Polio Virus Vaccine Market Forecast
  10.2.4 Brazil Inactivated Polio Virus Vaccine Market Forecast
10.3 APAC Inactivated Polio Virus Vaccine Forecast by Region (2024-2029)
  10.3.1 China Inactivated Polio Virus Vaccine Market Forecast
  10.3.2 Japan Inactivated Polio Virus Vaccine Market Forecast
  10.3.3 Korea Inactivated Polio Virus Vaccine Market Forecast
  10.3.4 Southeast Asia Inactivated Polio Virus Vaccine Market Forecast
  10.3.5 India Inactivated Polio Virus Vaccine Market Forecast
  10.3.6 Australia Inactivated Polio Virus Vaccine Market Forecast
10.4 Europe Inactivated Polio Virus Vaccine Forecast by Country (2024-2029)
  10.4.1 Germany Inactivated Polio Virus Vaccine Market Forecast
  10.4.2 France Inactivated Polio Virus Vaccine Market Forecast
  10.4.3 UK Inactivated Polio Virus Vaccine Market Forecast
  10.4.4 Italy Inactivated Polio Virus Vaccine Market Forecast
  10.4.5 Russia Inactivated Polio Virus Vaccine Market Forecast
10.5 Middle East & Africa Inactivated Polio Virus Vaccine Forecast by Region (2024-2029)
  10.5.1 Egypt Inactivated Polio Virus Vaccine Market Forecast
  10.5.2 South Africa Inactivated Polio Virus Vaccine Market Forecast
  10.5.3 Israel Inactivated Polio Virus Vaccine Market Forecast
  10.5.4 Turkey Inactivated Polio Virus Vaccine Market Forecast
  10.5.5 GCC Countries Inactivated Polio Virus Vaccine Market Forecast
10.6 Global Inactivated Polio Virus Vaccine Forecast by Type (2024-2029)
10.7 Global Inactivated Polio Virus Vaccine Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Sanofi
  11.1.1 Sanofi Company Information
  11.1.2 Sanofi Inactivated Polio Virus Vaccine Product Offered
  11.1.3 Sanofi Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Sanofi Main Business Overview
  11.1.5 Sanofi Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Inactivated Polio Virus Vaccine Product Offered
  11.2.3 GSK Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Serum Institute (Bilthoven Biologicals)
  11.3.1 Serum Institute (Bilthoven Biologicals) Company Information
  11.3.2 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Offered
  11.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Serum Institute (Bilthoven Biologicals) Main Business Overview
  11.3.5 Serum Institute (Bilthoven Biologicals) Latest Developments
11.4 IMBCA
  11.4.1 IMBCA Company Information
  11.4.2 IMBCA Inactivated Polio Virus Vaccine Product Offered
  11.4.3 IMBCA Inactivated Polio Virus Vaccine Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 IMBCA Main Business Overview
  11.4.5 IMBCA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Inactivated Polio Virus Vaccine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Type I
Table 3. Major Players of Type II
Table 4. Major Players of Type III
Table 5. Inactivated Polio Virus Vaccine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Table 8. Inactivated Polio Virus Vaccine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Table 11. Global Inactivated Polio Virus Vaccine Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Inactivated Polio Virus Vaccine Revenue Market Share by Player (2018-2023)
Table 13. Inactivated Polio Virus Vaccine Key Players Head office and Products Offered
Table 14. Inactivated Polio Virus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Inactivated Polio Virus Vaccine Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Inactivated Polio Virus Vaccine Market Size Market Share by Regions (2018-2023)
Table 19. Global Inactivated Polio Virus Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Inactivated Polio Virus Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Country (2018-2023)
Table 23. Americas Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Table 25. Americas Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Table 27. APAC Inactivated Polio Virus Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Region (2018-2023)
Table 29. APAC Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Table 31. APAC Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Table 33. Europe Inactivated Polio Virus Vaccine Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Country (2018-2023)
Table 35. Europe Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Table 37. Europe Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Inactivated Polio Virus Vaccine Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Inactivated Polio Virus Vaccine
Table 46. Key Market Challenges & Risks of Inactivated Polio Virus Vaccine
Table 47. Key Industry Trends of Inactivated Polio Virus Vaccine
Table 48. Global Inactivated Polio Virus Vaccine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Inactivated Polio Virus Vaccine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Inactivated Polio Virus Vaccine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Sanofi Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 53. Sanofi Inactivated Polio Virus Vaccine Product Offered
Table 54. Sanofi Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. GSK Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 58. GSK Inactivated Polio Virus Vaccine Product Offered
Table 59. GSK Main Business
Table 60. GSK Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. GSK Latest Developments
Table 62. Serum Institute (Bilthoven Biologicals) Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 63. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Product Offered
Table 64. Serum Institute (Bilthoven Biologicals) Main Business
Table 65. Serum Institute (Bilthoven Biologicals) Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Serum Institute (Bilthoven Biologicals) Latest Developments
Table 67. IMBCA Details, Company Type, Inactivated Polio Virus Vaccine Area Served and Its Competitors
Table 68. IMBCA Inactivated Polio Virus Vaccine Product Offered
Table 69. IMBCA Main Business
Table 70. IMBCA Inactivated Polio Virus Vaccine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. IMBCA Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Inactivated Polio Virus Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Inactivated Polio Virus Vaccine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Inactivated Polio Virus Vaccine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Inactivated Polio Virus Vaccine Sales Market Share by Country/Region (2022)
Figure 8. Inactivated Polio Virus Vaccine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Inactivated Polio Virus Vaccine Market Size Market Share by Type in 2022
Figure 10. Inactivated Polio Virus Vaccine in Hospital
Figure 11. Global Inactivated Polio Virus Vaccine Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Inactivated Polio Virus Vaccine in Clinic
Figure 13. Global Inactivated Polio Virus Vaccine Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Global Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2022
Figure 15. Global Inactivated Polio Virus Vaccine Revenue Market Share by Player in 2022
Figure 16. Global Inactivated Polio Virus Vaccine Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Inactivated Polio Virus Vaccine Market Size 2018-2023 ($ Millions)
Figure 18. APAC Inactivated Polio Virus Vaccine Market Size 2018-2023 ($ Millions)
Figure 19. Europe Inactivated Polio Virus Vaccine Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Inactivated Polio Virus Vaccine Market Size 2018-2023 ($ Millions)
Figure 21. Americas Inactivated Polio Virus Vaccine Value Market Share by Country in 2022
Figure 22. United States Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Region in 2022
Figure 27. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Type in 2022
Figure 28. APAC Inactivated Polio Virus Vaccine Market Size Market Share by Application in 2022
Figure 29. China Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Country in 2022
Figure 36. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Figure 37. Europe Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Figure 38. Germany Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Inactivated Polio Virus Vaccine Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Inactivated Polio Virus Vaccine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 52. APAC Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 53. Europe Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 55. United States Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 56. Canada Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 59. China Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 60. Japan Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 61. Korea Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 63. India Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 64. Australia Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 65. Germany Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 66. France Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 67. UK Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 68. Italy Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 69. Russia Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 70. Spain Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 73. Israel Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Inactivated Polio Virus Vaccine Market Size 2024-2029 ($ Millions)
Figure 76. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Inactivated Polio Virus Vaccine Market Size Market Share Forecast by Application (2024-2029)